Advertisements



Mallinckrodt says StrataGraft to be evaluated in Phase 3 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 13th, 2019

Mallinckrodt announces publication of results from Phase 1b trial of StrataGraft

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 13th, 2019

Mallinckrodt"s Phase 3 trial of terlipresin in HRS-1 meets primary endpoint

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 15th, 2019

Mallinckrodt"s stock shoots up after positive phase 3 trial data on HRS-1 treatment

Shares of Mallinckrodt PLC shot up 11% in premarket trading Thursday, after .....»»

Category: topSource: marketwatchAug 15th, 2019

Mallinckrodt halts Phase 2B trial investigating use of Acthar gel in ALS

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 16th, 2019

Mallinckrodt completes enrollment of Phase 3 terlipressin CONFIRM trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 14th, 2019

Mallinckrodt reports retrospective analysis on Phase 3 REVERSE trial data at ILC

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 15th, 2019

Mallinckrodt subsidiary completes patient enrollment for StrataGraft trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 12th, 2019

Mallinckrodt completes enrollment of Phase 4 clinical trial of H.P. Acthar Gel

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 28th, 2018

Celgene shares lift on positive results for cancer drug trial

Celgene Corp. shares rose 1.6% in Tuesday premarket trade after the company reported positive results from a phase 3 cancer trial after-hours the previous day. The trial evaluated Celgene's chemotherapy drug Revlimid .....»»

Category: topSource: marketwatchJul 24th, 2018

Mallinckrodt enrolls first patient in Phase 2 DMD trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 2nd, 2018

Endocyte Announces FDA"s Acceptance of Trial Endpoint Change

177Lu-PSMA-617, a prostate specific membrane antigen-targeted radioligand therapy, is Endocyte's (ECYT) lead program. It is being evaluated in a phase III study for mCRPC for PSMA-positiv.....»»

Category: personnelSource: nytSep 11th, 2018

Mallinckrodt completed open-label phase of Phase 4 H.P. Acthar Gel trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 5th, 2019

BioCardia expects DSMB readout of Phase III CardiAMP trial in Q3

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall7 hr. 6 min. ago

Aimmune enrolls first patient in Phase 2 trial of AR201

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall9 hr. 21 min. ago

AstraZeneca updates on Phase 3 NEPTUNE trial of Imfinzi plus tremelimumab

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall10 hr. 21 min. ago

Outlook Therapeutics completes patient enrollment for NORSE 1 Phase 3 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 20th, 2019

AstraZeneca reports Farxiga met primary endpoint in Phase 3 DAPA-HF trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 20th, 2019

Enlivex says committee recommends continued enrollment in Phase 1b trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 19th, 2019

Fulcrum Therapeutics intitiates Phase 2b clinical trial of losmapimod for FSHD

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 19th, 2019

Auris expects top-line results from Phase 1b trial of AM-201 in coming weeks

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 15th, 2019